Notícias e Atualizações de Emma Walmsley
Voltar ao PerfilReceba as últimas notícias, atualizações e conteúdo sobre Emma Walmsley. Não perca nenhuma fofoca ou novo conteúdo adulto dela.
GSK could double CEO Emma Walmsley’s pay to $27 million in bid to bring U.K. exec salaries in line with the U.S.
GSK could double its long-serving CEO Emma Walmsley’s pay packet to £21.6 million ($27.2 million)...
Emma Walmsley, big pharma’s first female CEO, to depart GSK
Emma Walmsley, the first woman to lead a big pharma company as CEO, will step down from that post De...
GSK’s boss Emma Walmsley to step down after eight-year tenure
GSK has appointed a new boss after announcing the departure of Dame Emma Walmsley following eight ye...
Emma Walmsley on leading and leaving GSK
"I'm going to say something super weird," Dame Emma Walmsley says, when asked about the moment an ac...
GSK CEO Emma Walmsley's total pay rises 51% to nearly 13 mln pounds in 2023
March 1 (Reuters) - GSK (GSK.L), opens new tab CEO Emma Walmsley's total remuneration rose 51% to 12...
Emma Walmsley’s impatient overhaul of GSK
"I'm not famous for my patience," Emma Walmsley remarks, as she discusses her oversight of GSK's AI ...
GSK employees perform anonymous ‘180’ surveys on their bosses, and CEO Emma Walmsley isn’t exempt
GSK CEO Emma Walmsley's $13 million salary is predicated on picking the right people to steer cuttin...
GSK CEO: Innovation is the secret to bringing down cost of overall healthcare
Emma Walmsley, GSK CEO, joins CNBC's 'Squawk on the Street' to discuss the company's most recent ear...
Bonus Interview: Emma Walmsley
In 2017 Emma Walmsley became the most powerful woman in corporate Britain. The boss of the drugmaker...
GSK Will Replace CEO Walmsley With a Company Insider. The Stock Is Up.
Emma Walmsley, the CEO who led the U.K. drugmaker GSK through the Covid-19 pandemic and the transfor...
The David Rubenstein Show: GSK CEO Emma Walmsley
GlaxoSmithKline Plc Chief Executive Officer Emma Walmsley talks about developing a Covid vaccine, wh...
GSK CEO Walmsley to step down, be succeeded by company’s commercial lead
Andrew covers the biopharma industry, scientific research, and public health across the continent. Y...
GSK CEO Emma Walmsley's total pay rises 51% to nearly 13 million pounds in 2023
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: GlaxoSmithKline CE...
GSK shares rally as chief Emma Walmsley to exit after eight years
The chief executive of pharmaceutical giant GSK has announced plans to step down from the company at...
Emma Walmsley
On the C-SPAN Networks: Emma Walmsley is a CEO for the GlaxoSmithKline with one video in the C-SPAN ...
GSK CEO Emma Walmsley Says Drugmaker Is ‘Betting Big’ on the US
GSK Plc is “betting big on the US” and engaged in constructive talks on drug pricing with US Pre...
Hands off our tax breaks, GSK boss Emma Walmsley tells Reeves as she bows out on a high
GSK boss Emma Walmsley has warned Chancellor Rachel Reeves against tinkering with the pharma industr...
GSK names new CEO to replace Emma Walmsley
To continue reading this content, please enable JavaScript in your browser settings and refresh this...
GSK CEO Emma Walmsley says it's ‘obnoxious’ when CEOs complain about their hard lives
GSK CEO Emma Walmsley has said she finds it “obnoxious” when company leaders complain about how ...
GSK buys out Novartis in $13 billion consumer healthcare shake-up
GlaxoSmithKline (GSK.L) is buying Novartis (NOVN.S) out of their consumer healthcare joint venture f...
GSK rewards CEO Emma Walmsley with 51% pay hike after beating sales, profit goals
With a 51% boost in pay in 2023, GSK's Emma Walmsley has gone from being one of the lowest-paid CEOs...
GSK CEO Emma Walmsley to Step Down
GSK GSK-2.07%decrease; red down pointing triangle said Chief Executive Emma Walmsley would step down...
GSK raises 2025 sales forecast after strong growth in specialty medicines
(Reuters) -GSK raised its 2025 sales and earnings expectations on Wednesday after third-quarter resu...
GSK boosted by cancer and HIV drugs as Emma Walmsley bows out
GSK has lifted its sales and profits targets after a boost from HIV and oncology drugs as chief exec...